SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Akums Drugs and Pharmaceuticals reports 66% drop in Q3 consolidated net profit

07 Feb 2025 Evaluate

Akums Drugs and Pharmaceuticals has reported results for third quarter ended December 31, 2024 (Q3FY25)

The company has reported 40.32% rise in net profit at Rs 41.17 crore for Q3FY25 as compared to Rs 29.34 crore for the same quarter in the previous year. Total income of the company decreased by 9.02% at Rs 371.25 crore for Q3FY25 as compared to Rs 408.04 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 65.99% fall in its net profit at Rs 66.31 crore for the quarter ended December 31, 2024 as compared to Rs 195.00 crore for the same quarter in the previous year. Total income of the company decreased by 6.12% at Rs 1024.97 crore for Q3FY25 as compared to Rs 1091.75 crore for the corresponding quarter previous year.

Akums Drugs & Pharma Share Price

532.80 -1.30 (-0.24%)
22-Apr-2026 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1657.70
Dr. Reddys Lab 1213.25
Cipla 1227.75
Zydus Lifesciences 927.65
Lupin 2305.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×